CTOs on the Move

Nutri-Mack

www.nutri-mack.com

 
Nutri-Mack is a Vineland, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Tom Bigbee Healthcare Authority

Tom Bigbee Healthcare Authority is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Demopolis, AL. To find more information about Tom Bigbee Healthcare Authority, please visit www.bwwmh.com

Thorek Memorial Hospital

Thorek Memorial Hospital is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Thorek Memorial Hospital is based in Chicago, IL. You can find more information on Thorek Memorial Hospital at www.thorek.org

Thomas Jefferson University Hospital

Thomas Jefferson University Hospital is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Philadelphia, PA. To find more information about Thomas Jefferson University Hospital, please visit www.jeffersonhospital.org

Foghorn Therapeutics

More than 20,000 genes make us human. Genes control critical aspects of health and disease — but what controls our genes? Foghorn® Therapeutics ($FHTX) is developing therapies based on a system that directs which genes our cells express, and when, where, and in what order. By manipulating this system with our unique Gene Traffic Control™ platform, Foghorn will change how genes turn “on” and “off.” Unlike approaches that edit genes, this novel way of thinking will alter what our DNA has in store for us—and rewrite destiny for millions of people living with disease. With Gene Traffic Control™ Foghorn is pioneering a new, major class of drug targets to develop unprecedented therapies for cancer and other serious diseases. We have already validated multiple targets, are in the process of developing drug candidates in multiple types of cancer and are beginning to explore other diseases.

Helicos BioSciences

Helicos BioSciences Corporation is developing instruments for ultra-high-throughput sequencing of DNA or RNA without amplification.